vs
Side-by-side financial comparison of PAVmed Inc. (PAVM) and ScanTech AI Systems Inc. (STAI). Click either name above to swap in a different company.
PAVmed Inc. is the larger business by last-quarter revenue ($996.0K vs $631.0K, roughly 1.6× ScanTech AI Systems Inc.). PAVmed Inc. runs the higher net margin — 6465.8% vs -1532.9%, a 7998.7% gap on every dollar of revenue.
PAVmed Inc. is a commercial-stage medical technology company that designs, develops and commercializes innovative diagnostic and therapeutic medical products. Its portfolio covers point-of-care diagnostics, interventional oncology and gastroenterology solutions, primarily serving healthcare providers and patients across the United States.
PAVM vs STAI — Head-to-Head
Income Statement — Q3 FY2024 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $996.0K | $631.0K |
| Net Profit | $64.4M | $-9.7M |
| Gross Margin | -38.7% | 27.6% |
| Operating Margin | -1162.4% | -773.2% |
| Net Margin | 6465.8% | -1532.9% |
| Revenue YoY | 25.9% | — |
| Net Profit YoY | 464.4% | — |
| EPS (diluted) | $1.44 | $-0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $631.0K | ||
| Q2 25 | — | $884.0K | ||
| Q1 25 | — | $346.1K | ||
| Q3 24 | $996.0K | — | ||
| Q2 24 | $979.0K | — | ||
| Q1 24 | $1.0M | — | ||
| Q4 23 | $1.0M | — | ||
| Q3 23 | $791.0K | — |
| Q3 25 | — | $-9.7M | ||
| Q2 25 | — | $-6.9M | ||
| Q1 25 | — | $-17.9M | ||
| Q3 24 | $64.4M | — | ||
| Q2 24 | $-10.8M | — | ||
| Q1 24 | $-15.2M | — | ||
| Q4 23 | $-14.0M | — | ||
| Q3 23 | $-17.7M | — |
| Q3 25 | — | 27.6% | ||
| Q2 25 | — | 14.3% | ||
| Q1 25 | — | 29.4% | ||
| Q3 24 | -38.7% | — | ||
| Q2 24 | -70.2% | — | ||
| Q1 24 | -72.7% | — | ||
| Q4 23 | -53.5% | — | ||
| Q3 23 | -124.9% | — |
| Q3 25 | — | -773.2% | ||
| Q2 25 | — | -440.1% | ||
| Q1 25 | — | -4503.9% | ||
| Q3 24 | -1162.4% | — | ||
| Q2 24 | -1397.8% | — | ||
| Q1 24 | -1389.7% | — | ||
| Q4 23 | -1561.7% | — | ||
| Q3 23 | -1963.1% | — |
| Q3 25 | — | -1532.9% | ||
| Q2 25 | — | -785.1% | ||
| Q1 25 | — | -5174.2% | ||
| Q3 24 | 6465.8% | — | ||
| Q2 24 | -1105.9% | — | ||
| Q1 24 | -1506.1% | — | ||
| Q4 23 | -1338.0% | — | ||
| Q3 23 | -2234.0% | — |
| Q3 25 | — | $-0.16 | ||
| Q2 25 | — | $-0.16 | ||
| Q1 25 | — | $-0.77 | ||
| Q3 24 | $1.44 | — | ||
| Q2 24 | $-1.19 | — | ||
| Q1 24 | $-2.62 | — | ||
| Q4 23 | $-1.90 | — | ||
| Q3 23 | $-2.38 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $765.0K | — |
| Total DebtLower is stronger | — | $17.7M |
| Stockholders' EquityBook value | $-4.9M | — |
| Total Assets | $30.6M | $5.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $765.0K | — | ||
| Q2 24 | $25.5M | — | ||
| Q1 24 | $25.5M | — | ||
| Q4 23 | $19.6M | — | ||
| Q3 23 | $26.4M | — |
| Q3 25 | — | $17.7M | ||
| Q2 25 | — | $17.7M | ||
| Q1 25 | — | $17.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $-4.9M | — | ||
| Q2 24 | $-73.9M | — | ||
| Q1 24 | $-68.8M | — | ||
| Q4 23 | $-53.8M | — | ||
| Q3 23 | $-43.3M | — |
| Q3 25 | — | $5.1M | ||
| Q2 25 | — | $4.6M | ||
| Q1 25 | — | $5.1M | ||
| Q3 24 | $30.6M | — | ||
| Q2 24 | $39.4M | — | ||
| Q1 24 | $37.3M | — | ||
| Q4 23 | $33.1M | — | ||
| Q3 23 | $42.0M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.9M | $-758.5K |
| Free Cash FlowOCF − Capex | $-8.9M | — |
| FCF MarginFCF / Revenue | -892.5% | — |
| Capex IntensityCapex / Revenue | 0.6% | 0.0% |
| Cash ConversionOCF / Net Profit | -0.14× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-758.5K | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-2.2M | ||
| Q3 24 | $-8.9M | — | ||
| Q2 24 | $-11.7M | — | ||
| Q1 24 | $-13.1M | — | ||
| Q4 23 | $-11.9M | — | ||
| Q3 23 | $-11.1M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-2.2M | ||
| Q3 24 | $-8.9M | — | ||
| Q2 24 | $-11.7M | — | ||
| Q1 24 | $-13.2M | — | ||
| Q4 23 | $-12.1M | — | ||
| Q3 23 | $-11.1M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | -166.0% | ||
| Q1 25 | — | -623.8% | ||
| Q3 24 | -892.5% | — | ||
| Q2 24 | -1190.9% | — | ||
| Q1 24 | -1302.1% | — | ||
| Q4 23 | -1149.4% | — | ||
| Q3 23 | -1404.2% | — |
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 2.0% | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 4.2% | — | ||
| Q4 23 | 17.4% | — | ||
| Q3 23 | 2.3% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | -0.14× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
